Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (611-620 of 1,398) with videos related to

Pageof 140
Sort By:
Science Signaling|March 8, 2012
Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2Devin T Worster, Tobias Schmelzle, Nicole L Solimini, et al.
Cell Reports|August 9, 2016
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic CancerAgnieszka K Witkiewicz, Uthra Balaji, Cody Eslinger, et al.
Cancer Cell|October 22, 2021
Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicityYing Jing, Yuan Liu, Qiang Li, et al.
Oncogene|May 29, 2003
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancersRobert Z Luo, Xianjun Fang, Rebecca Marquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
The American Journal of Pathology|April 3, 2012
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cellsHong Mu, Tiffany L Calderone, Michael A Davies, et al.
Cancer Research|March 3, 2006
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancerZendra Lee, Ramona F Swaby, Yuewei Liang, et al.
Transplantation|August 27, 1994
Evidence that increases in lymphocyte tyrosine phosphorylation precede cardiac allograft rejection. Effects of cyclosporine and potential use in clinical managementP W Tsao, G B Mills, R J Diaz, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 1, 1997
An overview of a multimedia benchmarking analysis for three risk assessment models: RESRAD, MMSOILS, and MEPASG F Laniak, J G Droppo, E R Faillace, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2007
Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cellsKaren Badour, Mary K H McGavin, Jinyi Zhang, et al.
Pageof 140

Showing results (611-620 of 1,398) with videos related to

Sort By:
Pageof 140
Science Signaling|March 8, 2012
Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2Devin T Worster, Tobias Schmelzle, Nicole L Solimini, et al.
Cell Reports|August 9, 2016
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic CancerAgnieszka K Witkiewicz, Uthra Balaji, Cody Eslinger, et al.
Cancer Cell|October 22, 2021
Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicityYing Jing, Yuan Liu, Qiang Li, et al.
Oncogene|May 29, 2003
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancersRobert Z Luo, Xianjun Fang, Rebecca Marquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
The American Journal of Pathology|April 3, 2012
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cellsHong Mu, Tiffany L Calderone, Michael A Davies, et al.
Cancer Research|March 3, 2006
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancerZendra Lee, Ramona F Swaby, Yuewei Liang, et al.
Transplantation|August 27, 1994
Evidence that increases in lymphocyte tyrosine phosphorylation precede cardiac allograft rejection. Effects of cyclosporine and potential use in clinical managementP W Tsao, G B Mills, R J Diaz, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 1, 1997
An overview of a multimedia benchmarking analysis for three risk assessment models: RESRAD, MMSOILS, and MEPASG F Laniak, J G Droppo, E R Faillace, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2007
Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cellsKaren Badour, Mary K H McGavin, Jinyi Zhang, et al.
Pageof 140